(1) Liu Dingkang#, Bao Lichen#, Zhu Haichao, Yue Yali, Tian Jing, Gao Xiangdong, Yin Jun. Microenvironment-responsive anti-PD-L1×CD3 bispecific T-cell engager for solid tumor immunotherapy, Journal of Controlled Release, 2023, 354: 606-614.

(2) Liu Dingkang#, Rong Haibo#, Chen Ye, Wang Qun, Qian Sijia, Ji Yue, Yao Wenbing, Yin Jun, Gao Xiangdong, Targeted disruption of mitochondria potently reverses multidrug resistance in cancer therapy, British Journal of Pharmacology, 2022, 179(13): 3346-3362.

(3) Liu Dingkang#, Chen Ye#, Wang Qun, Ji Yue, Bao Lichen, Yao Wenbing, Gao Xiangdong, Yin Jun, Tailored protein-conjugated DNA nanoplatform for synergistic cancer therapy, Journal of Controlled Release, 2022, 346: 250-259.

(4) Ji Yue#, Liu Dingkang#, Zhu Haichao, Bao Lichen, Chang Ruilong, Gao Xiangdong*, Yin Jun*. Unstructured Polypeptides as a Versatile Drug Delivery Technology[J]. Acta Biomaterialia. 2023 Jul 1; 164:74-93.

(5) Yin Jun#, Liu Dingkang#, Bao Lichen, Wang Qun, Chen Ye, Hou Shan, Yue Yali, Yao Wenbing, Gao Xiangdong, Tumor targeting and microenvironment-responsive multifunctional fusion protein for pro-apoptotic peptide delivery, Cancer Letters, 2019, 452: 38-50.

(6) 高向东; 尹骏; 刘定康; 姚文兵; 陈烨, 抗肿瘤靶向融合蛋白、其偶联物及用途, 2022-3-22, 中国, ZL 201811632324.1 (发明专利)